Treatment Decisions for Babies with Trisomy 13 and 18
Related Experiment Videos
Isabella Pallotto1, John D Lantos2
1Davidson College, Davidson, NC, USA.
Insights
Many infants with trisomy 13 and 18 face early death or severe impairment. This study examines the debate on life-sustaining interventions, considering quality of life and clinical decision-making for these conditions.
Area of Science:
- Medical Ethics
- Neonatal Care
- Genetics
Background:
- Trisomy 13 and trisomy 18 are severe genetic disorders associated with high infant mortality and significant cognitive impairment in survivors.
- A complex ethical debate exists regarding the appropriateness of life-sustaining interventions for infants diagnosed with these conditions.
Purpose of the Study:
- To explore the ethical considerations surrounding life-sustaining interventions for infants with trisomy 13 and 18.
- To analyze the portrayal of these conditions in pediatric medical literature and online parent support groups.
- To propose a framework for clinical decision-making in managing these complex cases.
Main Methods:
- Review of existing literature on trisomy 13 and 18.
- Content analysis of pediatric textbooks.
- Examination of social media support sites for parents of children with trisomies.
Main Results:
- Identified two primary viewpoints in the debate: one questioning the utility of interventions given poor outcomes, the other emphasizing potential quality of life.
- Analysis revealed how these conditions are represented in medical education and parental communities.
Conclusions:
- The ethical and clinical management of infants with trisomy 13 and 18 requires careful consideration of multiple perspectives.
- Further discussion and clear guidelines are needed to support families and healthcare providers in making difficult decisions.
Abstract:
Many babies with trisomy 13 and 18 die in the first year of life. Survivors all have severe cognitive impairment. There has been a debate among both professionals and parents about whether it is appropriate to provide life-sustaining interventions to babies with these serious conditions. On one side of the debate are those who argue that there is no point in providing invasive, painful, and expensive procedures when the only outcomes are either early death or survival with severe cognitive impairment. Others suggest that, although mortality is high and cognitive impairment universal, babies with these conditions have an acceptable quality of life. In this paper, we will discuss both points of view. We will review the ways in which these conditions are portrayed in pediatrics textbooks and on social media sites that offer support to parents. We will then suggest an appropriate way to deal with clinical decisions for babies with these trisomies.